Human T-cell growth factor: partial amino acid sequence, cDNA cloning, and organization and expression in normal and leukemic cells. 1984

S C Clark, and S K Arya, and F Wong-Staal, and M Matsumoto-Kobayashi, and R M Kay, and R J Kaufman, and E L Brown, and C Shoemaker, and T Copeland, and S Oroszlan

The partial amino acid sequences of human T-cell growth factors (TCGFs) isolated from normal peripheral blood lymphocytes and from a leukemia T-cell line (Jurkat) show that the amino-terminal sequences of the two proteins (15 residues) are identical. Oligonucleotides based on the published Jurkat TCGF DNA sequence were used to isolate six cDNA clones of TCGF mRNA from normal lymphocytes. The predicted amino acid sequence of normal lymphocyte TCGF was identical to the sequence of the Jurkat protein, showing that the differences in biochemical properties of the two proteins result from post-translational events. Amino acid and nucleotide sequence data suggest that TCGF is derived from a precursor polypeptide that is cleaved at the amino terminus but not at the carboxyl terminus. Hybridization of the cloned lymphocyte TCGF cDNA to cellular DNA and RNA strongly suggested that the TCGF gene is expressed as a single mRNA species from a single-copy gene. No differences in the organization of the TCGF gene in normal, leukemic, and human T-cell leukemia/lymphoma virus-infected cells was detected regardless of whether they produce TCGF or not.

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D011061 Poly A A group of adenine ribonucleotides in which the phosphate residues of each adenine ribonucleotide act as bridges in forming diester linkages between the ribose moieties. Adenine Polynucleotides,Polyadenylic Acids,Poly(rA),Polynucleotides, Adenine
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004262 DNA Restriction Enzymes Enzymes that are part of the restriction-modification systems. They catalyze the endonucleolytic cleavage of DNA sequences which lack the species-specific methylation pattern in the host cell's DNA. Cleavage yields random or specific double-stranded fragments with terminal 5'-phosphates. The function of restriction enzymes is to destroy any foreign DNA that invades the host cell. Most have been studied in bacterial systems, but a few have been found in eukaryotic organisms. They are also used as tools for the systematic dissection and mapping of chromosomes, in the determination of base sequences of DNAs, and have made it possible to splice and recombine genes from one organism into the genome of another. EC 3.21.1. Restriction Endonucleases,DNA Restriction Enzyme,Restriction Endonuclease,Endonuclease, Restriction,Endonucleases, Restriction,Enzymes, DNA Restriction,Restriction Enzyme, DNA,Restriction Enzymes, DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S C Clark, and S K Arya, and F Wong-Staal, and M Matsumoto-Kobayashi, and R M Kay, and R J Kaufman, and E L Brown, and C Shoemaker, and T Copeland, and S Oroszlan
January 1987, Differentiation; research in biological diversity,
S C Clark, and S K Arya, and F Wong-Staal, and M Matsumoto-Kobayashi, and R M Kay, and R J Kaufman, and E L Brown, and C Shoemaker, and T Copeland, and S Oroszlan
November 1986, Nucleic acids research,
S C Clark, and S K Arya, and F Wong-Staal, and M Matsumoto-Kobayashi, and R M Kay, and R J Kaufman, and E L Brown, and C Shoemaker, and T Copeland, and S Oroszlan
January 1983, Nature,
S C Clark, and S K Arya, and F Wong-Staal, and M Matsumoto-Kobayashi, and R M Kay, and R J Kaufman, and E L Brown, and C Shoemaker, and T Copeland, and S Oroszlan
October 1984, Journal of immunology (Baltimore, Md. : 1950),
S C Clark, and S K Arya, and F Wong-Staal, and M Matsumoto-Kobayashi, and R M Kay, and R J Kaufman, and E L Brown, and C Shoemaker, and T Copeland, and S Oroszlan
September 1989, Biochemical and biophysical research communications,
S C Clark, and S K Arya, and F Wong-Staal, and M Matsumoto-Kobayashi, and R M Kay, and R J Kaufman, and E L Brown, and C Shoemaker, and T Copeland, and S Oroszlan
November 1989, Blood,
S C Clark, and S K Arya, and F Wong-Staal, and M Matsumoto-Kobayashi, and R M Kay, and R J Kaufman, and E L Brown, and C Shoemaker, and T Copeland, and S Oroszlan
January 1992, Growth factors (Chur, Switzerland),
S C Clark, and S K Arya, and F Wong-Staal, and M Matsumoto-Kobayashi, and R M Kay, and R J Kaufman, and E L Brown, and C Shoemaker, and T Copeland, and S Oroszlan
October 1983, Proceedings of the National Academy of Sciences of the United States of America,
S C Clark, and S K Arya, and F Wong-Staal, and M Matsumoto-Kobayashi, and R M Kay, and R J Kaufman, and E L Brown, and C Shoemaker, and T Copeland, and S Oroszlan
March 1984, Proceedings of the National Academy of Sciences of the United States of America,
S C Clark, and S K Arya, and F Wong-Staal, and M Matsumoto-Kobayashi, and R M Kay, and R J Kaufman, and E L Brown, and C Shoemaker, and T Copeland, and S Oroszlan
August 1989, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!